Kanker Payudara

Navigating the Intersection of GLP-1 Medications and Breast Cancer: What Science Tells Us Today

• Survivorship and Post-Treatment

Navigating the Intersection of GLP-1 Medications and Breast Cancer: What Science Tells Us Today

Pevita Pearce October 15, 2026

By Editorial Staff, based on insights from Douglas Feil, NBCF Chief Program Officer Medical Disclaimer: The information...

Read More Read more about Navigating the Intersection of GLP-1 Medications and Breast Cancer: What Science Tells Us Today

Beyond Implants: The Rise of Autologous Fat Transfer in Post-Mastectomy Breast Reconstruction

• Breast Cancer Surgery and Reconstruction

Beyond Implants: The Rise of Autologous Fat Transfer in Post-Mastectomy Breast Reconstruction

Nila Kartika Wati October 15, 2026

For decades, women undergoing mastectomy have faced a binary choice for breast reconstruction: the insertion of silicone...

Read More Read more about Beyond Implants: The Rise of Autologous Fat Transfer in Post-Mastectomy Breast Reconstruction

The Rebirth of a Biotech Legacy: Armed Cell Therapeutics Acquires Lakefront’s CAR-T Portfolio

• Chemotherapy and Targeted Therapy

The Rebirth of a Biotech Legacy: Armed Cell Therapeutics Acquires Lakefront’s CAR-T Portfolio

Siti Muinah October 15, 2026

In a strategic pivot that breathes new life into a discarded pipeline, the newly minted Belgian startup...

Read More Read more about The Rebirth of a Biotech Legacy: Armed Cell Therapeutics Acquires Lakefront’s CAR-T Portfolio

A Visionary Appointment: Patrick J. Sinko Named Chief Science Officer of the American Association of Pharmaceutical Scientists

• Chemotherapy and Targeted Therapy

A Visionary Appointment: Patrick J. Sinko Named Chief Science Officer of the American Association of Pharmaceutical Scientists

Sagoh October 15, 2026

The American Association of Pharmaceutical Scientists (AAPS) has announced the appointment of Dr. Patrick J. Sinko, Ph.D.,...

Read More Read more about A Visionary Appointment: Patrick J. Sinko Named Chief Science Officer of the American Association of Pharmaceutical Scientists

Illuminating the Shadows: The Global Effort to Defeat Metastatic Breast Cancer

• Metastatic Breast Cancer Research

Illuminating the Shadows: The Global Effort to Defeat Metastatic Breast Cancer

Basiran October 15, 2026

NEW YORK, NY — As Breast Cancer Awareness Month unfolds across the globe, the familiar sea of...

Read More Read more about Illuminating the Shadows: The Global Effort to Defeat Metastatic Breast Cancer

A Fractured Partnership: Assessing the Fallout of the U.S. Withdrawal from the World Health Organization

• Global Breast Cancer Awareness

A Fractured Partnership: Assessing the Fallout of the U.S. Withdrawal from the World Health Organization

Pevita Pearce October 15, 2026

Introduction: The Erosion of a Decades-Long Alliance The World Health Organization (WHO) has long stood as the...

Read More Read more about A Fractured Partnership: Assessing the Fallout of the U.S. Withdrawal from the World Health Organization

The New Frontier of Metastatic Breast Cancer: How Research and Accessibility are Redefining Stage IV Care

• Global Breast Cancer Awareness

The New Frontier of Metastatic Breast Cancer: How Research and Accessibility are Redefining Stage IV Care

Azzam Bilal Chamdy October 15, 2026

Metastatic breast cancer (mBC)—clinically classified as Stage IV breast cancer—represents the most challenging iteration of the disease....

Read More Read more about The New Frontier of Metastatic Breast Cancer: How Research and Accessibility are Redefining Stage IV Care

Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

• Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Jia Lissa October 15, 2026

NORMAN, OK – In a significant advancement for cancer research, scientists at the University of Oklahoma have...

Read More Read more about Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Vanda Pharmaceuticals Halts Social Anxiety Drug Program Amidst Trial Setback, Highlighting Industry-Wide Challenges

• Medical Research and Clinical Trials

Vanda Pharmaceuticals Halts Social Anxiety Drug Program Amidst Trial Setback, Highlighting Industry-Wide Challenges

Lina Irawan October 15, 2026

Washington D.C. – Vanda Pharmaceuticals has announced a significant pause in its late-stage clinical program for VQW-765,...

Read More Read more about Vanda Pharmaceuticals Halts Social Anxiety Drug Program Amidst Trial Setback, Highlighting Industry-Wide Challenges

Navigating the Nexus: GLP-1 Medications and Breast Cancer – Emerging Insights and Crucial Conversations

• Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – Emerging Insights and Crucial Conversations

Siti Muinah October 15, 2026

By Douglas Feil, Chief Program Officer, National Breast Cancer Foundation (NBCF) The landscape of medical treatment is...

Read More Read more about Navigating the Nexus: GLP-1 Medications and Breast Cancer – Emerging Insights and Crucial Conversations